Opening new frontiers with catalytic nucleic acids in miRNA inhibition
The concept of utilizing synthetic nucleic acids and their conjugates with biologically active molecules as RNA-targeted therapeutic agents represents a powerful strategy in the treatment of human pathologies. Recent research demonstrates that neoplastic development is closely associated with dysreg...
Saved in:
| Main Authors: | Olga Patutina, Svetlana Miroshnichenko, Daria Chiglintseva, Marina Zenkova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1604711/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CircRNA-based AntimiR therapy: A novel approach to hypertension treatment
by: Vahideh Tarhriz, et al.
Published: (2025-08-01) -
Mechanisms of alleviating sepsis-induced rat lung and kidney damage by inhibiting expression of miRNA-939
by: Anwaier Apizi, et al.
Published: (2025-06-01) -
Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19
by: Seyedeh Hoda Alavizadeh, et al.
Published: (2022-05-01) -
A Photo-Controllable DNAzyme-Based Nanosensor for miRNA Imaging in Living Cells
by: Yanfei Zhang, et al.
Published: (2025-04-01) -
MicroRNA-dependent mechanisms of taxane resistance in breast cancer
by: V. S. Apollonova, et al.
Published: (2022-12-01)